Cargando…
Langerhans Cell Histiocytosis with Good Response to Low-Dose Imatinib: Case Report and Literature Review
Langerhans cell histiocytosis (LCH) is a rare neoplastic disease characterized by infiltration of histiocytes and dendritic cells into body organs. While treatment is better established in pediatrics, there is still no consensus on therapy in the adult population. Imatinib has shown promising result...
Autores principales: | Abdulgayoom, Mohammed, Mudawi, Deena, Lengyel, Zsolt, Abo Samra, Hayan, Alshurafa, Awni, Yassin, Mohamed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355039/ https://www.ncbi.nlm.nih.gov/pubmed/37476563 http://dx.doi.org/10.1159/000531230 |
Ejemplares similares
-
Congenital Langerhans cell histiocytosis: a good prognosis
disease?
por: Frade, Ana Paula, et al.
Publicado: (2017) -
A Challenging Case of a Patient With Immune Thrombocytopenic Purpura on Eltrombopag Who Developed Atrial Fibrillation: An Anticoagulation Dilemma
por: Yasin, Ahmed K, et al.
Publicado: (2023) -
Langerhans cell histiocytosis
por: Aruna, D. R., et al.
Publicado: (2011) -
Langerhans cell histiocytosis
por: Kumar, Manish, et al.
Publicado: (2018) -
Radioactive Iodine-Induced Chronic Myeloid Leukemia in a Patient With Graves' Disease: A Case Report
por: Yasin, Ahmed K, et al.
Publicado: (2023)